Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 17, 2009
Obesity and cancer: the role of dysfunctional adipose tissueRob C M van Kruijsdijk, Elsken van der Wall, Frank L J VisserenNederlands Tijdschrift Voor Geneeskunde|November 16, 2012
[Competing risks in clinical research]Rob C M van Kruijsdijk, Marinus J C Eijkemans, Frank L J VisserenCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2013
Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndromeRob C M van Kruijsdijk, Yolanda van der Graaf, Petra H M Peeters, et al.Annals of Hematology|May 1, 2018
Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literatureNyanza K L M Timmers, Josanne S de Maar, Rob C M van Kruijsdijk, et al.Journal of Nephrology|March 30, 2020
Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? : Two case reports and literature reviewRob C M van Kruijsdijk, Alferso C Abrahams, Tri Q Nguyen, et al.Cancer Epidemiology|December 3, 2014
The relation between resting heart rate and cancer incidence, cancer mortality and all-cause mortality in patients with manifest vascular diseaseRob C M van Kruijsdijk, Yolanda van der Graaf, Remy H H Bemelmans, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 9, 2025
Risk of deficient mismatch repair colorectal cancer and precursors after kidney transplantation: A nationwide studyKoen Zwart, Rob C M van Kruijsdijk, Valentina Angerilli, et al.Heart (British Cardiac Society)|December 6, 2014
Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy womenRob C M van Kruijsdijk, Frank L J Visseren, Paul M Ridker, et al.Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancerJohannes J M Kwakman, Rob C M van Kruijsdijk, Sjoerd G Elias, et al.Clinical Kidney Journal|September 26, 2022
Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect predictionRob C M van Kruijsdijk, Robin W M Vernooij, Michiel L Bots, et al.Pageof 2